Progenics

From Verify.Wiki
Jump to: navigation, search

Progenics Pharmaceuticals, Inc. is developing innovative medicines for oncology, with a pipeline that includes several product candidates in later-stage clinical development. Progenics has two commercial products, RELISTOR® (methylnaltrexone bromide) for opioid-induced constipation, which is partnered with Bausch Health Companies, Inc.; and AZEDRA, for the treatment of unresectable, locally advanced or metastatic pheochromocytoma or paraganglioma (rare neuroendocrine tumors of neural crest origin) who require systemic anticancer therapy.

QuickUpload1048 20170727120829.jpg
http://www.progenics.com
Type Public
Founded 1988
Headquarters New York, New York
Number of employees 51-200 employees


History

Controversies

Top 5 Recent Tweets

DateAuthorComment
July 28, 2022CureNETsIf you missed our 2022 KNOW YOUR NETs Conference you can stream the entire conference here https://t.co/knSF6AXzLa… https://t.co/3qTUNkLauG
July 28, 2022ProgenicsCBUnique Banking Technique & Storage

Equipment

All of our equipment meet the highest quality standards.… https://t.co/fMi86zQlMn
July 26, 2022urotodayTumor Board reviewing locally adv pT3N1M0 #ProstateCancer. @CaPsurvivorship is joined by Andrei Iagaru, @geoffsonn… https://t.co/ABRm2TsmqS


Top 5 Recent News Headlines

Top 5 Lifetime Tweets

Top 5 Lifetime News Headlines

Verification history